The patient is a 45-year-old male who is planning to undergo surgery. He has a medical history of hypertension, type 2 diabetes, and hyperlipidemia. 

In terms of his hypertension, the patient was diagnosed five years ago and has been on a combination of metoprolol and lisinopril for blood pressure control. His blood pressure has been well controlled within the normal range for the past two years. 

The patient was also diagnosed with type 2 diabetes ten years ago. He manages his diabetes with diet and exercise, as well as oral medications, specifically metformin and glipizide. His HbA1c levels have remained in the target range of less than 7% for the past year. 

In addition to hypertension and diabetes, the patient has a history of hyperlipidemia. He started taking atorvastatin seven years ago, and his lipid profile has shown significant improvement with LDL levels consistently below 100 mg/dL. 

Apart from these chronic conditions, the patient has a history of a cholecystectomy performed seven years ago due to symptomatic gallstones. The surgery was uneventful, and the patient recovered well without any complications. 

During his preoperative assessment, the patient's physical examination was unremarkable, with normal heart and lung sounds. Routine blood work, including complete blood count, liver function tests, and renal function tests, were within normal limits. 

The patient's surgical procedure is an elective hernia repair. During a routine preoperative chest x-ray, an incidental finding of an asymptomatic pulmonary nodule was noted. A CT scan of the chest was subsequently done, and the nodule was found to be non-cancerous. 

The patient has been counseled on the risks and benefits of the surgery, including the potential for bleeding, infection, and wound complications. He understands the importance of discontinuing his antihypertensive and antidiabetic medications prior to the surgery based on the surgeon's recommendations. 

For the surgery, the patient will receive general anesthesia. Appropriate antibiotic prophylaxis will be administered before the incision is made. Postoperatively, the patient will be closely monitored for pain control, wound healing, and signs of infection. 

In terms of the patient's postoperative course, he recovered well from the hernia repair surgery. He experienced normal wound healing without any signs of infection or dehiscence. Pain control was effectively managed with opiate analgesics initially, followed by a transition to non-opioid pain medications as tolerated. 

The patient was able to resume his regular diet the day after surgery without any gastrointestinal issues. His blood pressure was closely monitored, and he was restarted on his antihypertensive medications on the second day postoperatively. 

In terms of glycemic control, the patient's blood glucose levels were closely monitored and managed with a sliding scale insulin regimen. His diabetes remained well controlled during the postoperative period, with blood glucose levels within the target range. 

The patient's lipid profile was not affected by the surgery, and his atorvastatin therapy was continued postoperatively. 

The patient's postoperative recovery was uneventful, and he was discharged from the hospital on the fifth day after surgery. He was instructed to continue his medications as prescribed and to follow up with his primary care physician in one week to monitor his surgical incision and overall recovery. 

The patient did not experience any postoperative complications such as wound infections, hematoma formation, or respiratory issues. Additionally, there were no signs of acute renal failure during the postoperative period. 

Overall, the patient's surgery was successful without any significant complications or setbacks. He is advised to maintain routine follow-up appointments with his healthcare team to monitor his chronic conditions and ensure continued good health.